Viewing StudyNCT00973076



Ignite Creation Date: 2024-05-05 @ 9:51 PM
Last Modification Date: 2024-10-26 @ 10:10 AM
Study NCT ID: NCT00973076
Status: COMPLETED
Last Update Posted: 2011-06-15
First Post: 2009-09-07

Brief Title: Study to Assess the Safety and Tolerability of the Tor Kinase Inhibitor AZD8055
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Advanced Solid Malignancies
Cancer
Solid Tumors
Keywords:
Name View
Japanese View
Phase I cancer View
solid tumors View
advanced solid malignancies View
dose escalation View
mTOR Kinase Inhibitor View